Endometrial and cervical cancers require careful staging and pathology for effective treatment decisions. Lymph node involvement plays a crucial role in prognosis. Differentiating between low-grade and aggressive tumours is essential for treatment strategies. Immunotherapy is explored for advanced cases, focusing on patient selection. Standard care includes chemoradiotherapy, with ongoing trials assessing immunotherapy's effectiveness. More data is needed to enhance treatment protocols and improve patient outcomes.